NEW
Elonide

Elonide Overdosage

mometasone

Manufacturer:

Hoe Pharma

Distributor:

Zuellig Pharma
Full Prescribing Info
Overdosage
Because of the negligible (≤0.1%) systemic bioavailability of ELONIDE Nasal Spray, overdosage is unlikely to require any therapy other than observation, followed by initiation of the appropriate prescribed dosage. Inhalation or oral administration of excessive doses of corticosteroids may lead to suppression of HPA axis function.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in